Gsk (GSK) Income towards Parent Company (2009 - 2026)
Gsk (GSK) posted Income towards Parent Company of $2.92 billion for the quarter ended Sep 8, 2026.
Gsk (GSK) Income towards Parent Company (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 8, 2026, Income towards Parent Company at Gsk was $3.16 billion; for the year ended Dec 31, 2025, it was $7.54 billion, up 129.0% from the prior year.
- Annual Income towards Parent Company shows a five-year compound annual growth rate of 0.4% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Income towards Parent Company was $3.29 billion in the year ended Dec 31, 2024 (-46.3%), $6.13 billion in the year ended Dec 31, 2023 (-66.9%), $18.51 billion in the year ended Dec 31, 2022 (+206.8%) and $6.03 billion in the year ended Dec 31, 2021 (-18.3%).
- The figure for the quarter ended Sep 8, 2026 stands as the highest quarterly Income towards Parent Company since the quarter ended Sep 30, 2022.
- On a year-over-year basis, Income towards Parent Company increased in four of the last five quarters, with growth averaging 10.3%.
- The strongest year-over-year quarter for Income towards Parent Company in the past five years was the quarter ended Sep 30, 2022, with growth of 692.0%; the weakest was the quarter ended Sep 30, 2023, with a decline of 85.5%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 583.63 Mn |
| Mar 31, 2026 | 2.34 Bn |
| Dec 31, 2025 | -2.68 Bn |
| Sep 30, 2025 | 2.72 Bn |
| Jun 30, 2025 | 1.93 Bn |
| Mar 31, 2025 | 2.05 Bn |
| Dec 31, 2024 | 531.37 Mn |
| Sep 30, 2024 | -75.36 Mn |
| Jun 30, 2024 | 1.48 Bn |
| Mar 31, 2024 | 1.33 Bn |
| Dec 31, 2023 | 434.40 Mn |
| Sep 30, 2023 | 1.85 Bn |
| Jun 30, 2023 | 2.03 Bn |
| Mar 31, 2023 | 1.81 Bn |
| Dec 31, 2022 | 1.75 Bn |
| Sep 30, 2022 | 12.75 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 2.42 Bn |
| Dec 31, 2021 | 1.01 Bn |
| Sep 30, 2021 | 1.61 Bn |
Gsk Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();